New Delhi, February 27 Drug maker Lupin announced on Friday that it has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing facility in Goa.The company stated that it has received the EIR with a satisfactory Voluntary Action Indicated (VAI)...